摘要
目的 观察蒿甲醚伍用伯氨喹治疗恶性疟的疗效和副作用。 方法 在中非共和国选择恶性疟12 1例 ,随机分为两组。伍用组 :口服蒿甲醚 80mg ,qd× 5d ,首日蒿甲醚 16 0mg加服伯氨喹 3片 (含基质 7 5mg ,qd× 3～ 4d)治疗 32例 ;肌注蒿甲醚加服伯氨喹 ,治疗 2 9例 ;对照组 :单用口服蒿甲醚治疗 33例和肌注蒿甲醚治疗 2 7例 ,B组、C组和D组所用剂量与疗程均同A组。上述病例于用药前及后 6、 14、 2 1、及 2 8d各随访1次 ,密切观察病例的临床症状与体征变化。 结果 A组、B组、C组和D组病例的平均退热时间分别为(47 6± 15 7)、 (36 9± 10 7)、 (48 5± 18 4 )和 (42 2± 9 5 )h。其临床治愈率依次为 84 4 %、 10 0 %、 90 1和96 3% ,其复燃率依次为 6 3%、 3 4 %、 2 1 2 %和 18 5 %。 4组药物副作用均轻。 结论 蒿甲醚伍用伯氨喹及单用蒿甲醚 (口服或肌注 )对恶性疟治疗作用均良好 。
Objective To evaluate the efficacy and side effects of artemether combined with primaquine in the treatment of falciparum malaria. Methods Randomization and comparison methods were used in 121 falciparum malaria cases in the Republic of Central Africa.Sixty one cases were treated with artemether combined with primaquine(Group A used artemether orally,Group B used artemether intramuscularly).And 60 cases received single artemether (Group C used artemether orally,Group D used artemether intramuscularly ) were taken as control. Results In Group A and B the mean fever clearance time were 47 6±15 7 and 36 9±10 7 hours, clinical cure rates 84 4% and 100%, relapse rates 6 3% and 3 4% ,respectively.In Group C and D the mean fever clearance time were 48 2±18 4 and 42 2±9 5 hours,clinical cure rates 90 1% and 96 3%, relapse rates 21 2% and 18 5%,respectively.Side effects in cases of all groups were mild. Conclusion Artemether combined with primaquine and single artemether(via both routes) showed good therapeutic effects in falciparum malaria cases, while artemether combined with primaquine was more effective than single artemether in reducing relapes rate of malaria.
出处
《中国寄生虫学与寄生虫病杂志》
CAS
CSCD
北大核心
2001年第5期308-309,共2页
Chinese Journal of Parasitology and Parasitic Diseases
关键词
疟疾
恶性疟
抗疟药物
蒿甲醚
伯氨喹
临床疗效
Malaria, falciparum malaria, antimalarials, artemether, primaquine, clinical effect
